Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer
Authors
Keywords
chemoresistance, lipid-modified platinates, non-small cell lung cancer, small interfering RNA, <em class=EmphasisTypeItalic >survivin</em>
Journal
PHARMACEUTICAL RESEARCH
Volume 33, Issue 12, Pages 2943-2953
Publisher
Springer Nature
Online
2016-08-16
DOI
10.1007/s11095-016-2016-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-223 Induced Repolarization of Peritoneal Macrophages Using CD44 Targeting Hyaluronic Acid Nanoparticles for Anti-Inflammatory Effects
- (2016) Thanh-Huyen Tran et al. PLoS One
- Combinatorial-Designed Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-Type and Resistant Non-Small-Cell Lung Cancer Cells
- (2015) Ana Vanessa Nascimento et al. MOLECULAR PHARMACEUTICS
- Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy
- (2015) Young-Dong Kim et al. Nanomedicine
- A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3†
- (2014) Mircea Gabriel Stoleriu et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- First-Line Chemotherapy Treatment of Advanced Non–Small-Cell Lung Cancer: Does Cisplatin versus Carboplatin Make a Difference?
- (2014) Marcello Tiseo et al. Journal of Thoracic Oncology
- Small RNA combination therapy for lung cancer
- (2014) W. Xue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Mechanisms of RNA Interference
- (2013) Ross C. Wilson et al. Annual Review of Biophysics
- The Effect of Ligand Lipophilicity on the Nanoparticle Encapsulation of Pt(IV) Prodrugs
- (2013) Timothy C. Johnstone et al. INORGANIC CHEMISTRY
- In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles
- (2013) Shanthi Ganesh et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced Intrapulmonary Delivery of Anticancer siRNA for Lung Cancer Therapy Using Cationic Ethylphosphocholine-based Nanolipoplexes
- (2013) Gayong Shim et al. MOLECULAR THERAPY
- Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
- (2013) Shanthi Ganesh et al. Molecular Therapy-Nucleic Acids
- Downregulation of Cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9
- (2012) Zhe Qian et al. BMC CANCER
- Anticancer Platinum (IV) Prodrugs with Novel Modes of Activity
- (2011) Chee Fei Chin et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Pt(IV) complexes as prodrugs for cisplatin
- (2011) Yi Shi et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started